| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.61B | 1.74B | 1.79B | 1.78B | 2.67B |
| Gross Profit | 375.68M | 444.49M | 481.35M | 471.11M | 788.90M |
| EBITDA | 115.62M | 166.68M | -551.35M | 145.80M | 410.72M |
| Net Income | 13.20M | 14.58M | -449.98M | 93.39M | 56.81M |
Balance Sheet | |||||
| Total Assets | 1.84B | 1.83B | 1.83B | 2.25B | 2.22B |
| Cash, Cash Equivalents and Short-Term Investments | 223.66M | 243.30M | 286.77M | 247.32M | 358.00M |
| Total Debt | 2.33M | 4.23M | 12.06M | 15.41M | 25.46M |
| Total Liabilities | 871.82M | 876.86M | 889.22M | 851.90M | 933.35M |
| Stockholders Equity | 885.56M | 874.04M | 868.92M | 1.33B | 1.23B |
Cash Flow | |||||
| Free Cash Flow | -8.53M | -21.98M | 62.85M | -77.90M | -290.73M |
| Operating Cash Flow | 4.95M | -15.63M | 66.03M | -71.02M | -282.82M |
| Investing Cash Flow | -12.54M | -12.70M | -11.22M | -32.71M | -289.25M |
| Financing Cash Flow | -18.51M | -15.25M | -15.36M | -6.95M | -88.74M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$734.91M | 3.05 | 8.89% | 6.25% | 3.66% | 10.37% | |
70 Outperform | HK$219.42M | 1.77 | 15.16% | 11.22% | 4.17% | 10.89% | |
70 Outperform | HK$330.68M | 4.93 | 5.84% | 3.90% | -6.48% | -24.68% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
49 Neutral | HK$238.63M | 2.21 | 3151.98% | ― | -4.36% | 1481.82% | |
47 Neutral | HK$166.44M | 13.11 | 1.53% | ― | -7.13% | -14.57% |